Effect of vitamin D supplementation on insulin resistance and glycaemic control in prediabetes: A systematic review and meta-analysis

Diabetic Medicine

Volumn 33, Issue 3, 2016, Pages 290-299

  Poolsup, N ^a   Suksomboon, Naeti ^b   Plordplong, N ^b  

^a SILPAKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; HEMOGLOBIN A1C; VITAMIN D; GLUCOSE BLOOD LEVEL;

ARTICLE; CLINICAL ASSESSMENT; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; META ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DIETARY SUPPLEMENT; DRUG EFFECTS; METABOLISM; VITAMIN D DEFICIENCY;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; HUMANS; INSULIN RESISTANCE; NUTRITION THERAPY; PREDIABETIC STATE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84958767427     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12893     Document Type: Article

References (62)

1. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013; 36(Suppl. 1): S11-S66.
2. Buysschaert M, Bergman M. Definition of prediabetes. Med Clin North Am 2011; 95: 289-297.
3. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30: 753-759.
4. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
5. DeFronzo RA, Abdul-Ghani MA. Preservation of beta-cell function: the key to diabetes prevention. J Clin Endocrinol Metab 2011; 96: 2354-2366.
6. Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 2013; 36: 1422-1428.
7. Pittas AG, Nelson J, Mitri J, Hillmann W, Garganta C, Nathan DM et al. Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the diabetes prevention program. Diabetes Care 2012; 35: 565-573.
8. Dutta D, Maisnam I, Shrivastava A, Sinha A, Ghosh S, Mukhopadhyay P et al. Serum vitamin-D predicts insulin resistance in individuals with prediabetes. Indian J Med Res 2013; 138: 853-860.
9. Sung CC, Liao MT, Lu KC, Wu CC. Role of vitamin D in insulin resistance. J Biomed Biotechnol 2012; 2012: 1-12.
10. Ding C, Gao D, Wilding J, Trayhurn P, Bing C. Vitamin D signalling in adipose tissue. Br J Nutr 2012; 108: 1915-1923.
11. Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophys 2012; 523: 123-133.
12. Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, Stahelin HB et al. In situ detection of 1, 25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 2001; 33: 19-24.
13. Han S, Chiang JY. Mechanism of vitamin D receptor inhibition of cholesterol 7 alpha-hydroxylase gene transcription in human hepatocytes. Drug Metab Dispos 2009; 37: 469-478.
14. Eliades M, Pittas AG. Vitamin D and type 2 diabetes. Clin Rev Bone Miner Metab 2009; 7: 185-198.
15. Mitri J, Pittas AG. Vitamin D and diabetes. Endocrinol Metab Clin North Am 2014; 43: 205-232.
16. Seida JC, Mitri J, Colmers IN, Majumdar SR, Davidson MB, Edwards AL et al. Effect of Vitamin D3 Supplementation on Improving Glucose Homeostasis and Preventing Diabetes: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab 2014; 99: 3551-3560.
17. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.
18. Bosworth C, de Boer IH. Impaired vitamin D metabolism in CKD. Semin Nephrol 2013; 33: 158-168.
19. Burris HH, Camargo CA. Vitamin D and gestational diabetes mellitus. Curr Diab Rep 2014; 14: 451.
20. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
21. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000; 85: 4426-4433.
22. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis. Chichester, UK: John Wiley & Sons Ltd, 2009.
23. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Chichester, UK: John Wiley & Sons Ltd, 2008.
24. Pikilidou MI, Lasaridis AN, Sarafidis PA, Befani CD, Koliakos GG, Tziolas IM et al. Insulin sensitivity increase after calcium supplementation and change in intraplatelet calcium and sodium-hydrogen exchange in hypertensive patients with type 2 diabetes. Diabet Med 2009; 26: 211-219.
25. Sanchez M, de la Sierra A, Coca A, Poch E, Giner V, Urbano-Marquez A. Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients. Hypertension 1997; 29: 531-536.
26. Nikooyeh B, Neyestani TR, Farvid M, Alavi-Majd H, Houshiarrad A, Kalayi A et al. Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 2011; 93: 764-771.
27. The Expert Committee on the Diagnosis and Classification of Diabetes. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
28. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr 2010; 103: 549-555.
29. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
30. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30: 980-986.
31. de Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV, Kestenbaum B et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 2008; 31: 701-707.
32. Jorde R, Sneve M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010; 267: 462-472.
33. Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011; 94: 486-494.
34. Harris SS, Pittas AG, Palermo NJ. A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes Metab 2012; 14: 789-794.
35. Iraj B, Aminorroaya A, Amini M. Does the intramuscular injection of vitamin D increase insulin resistance? J Res Pharm Pract 2012; 1: 60-65.
36. Davidson MB, Duran P, Lee ML, Friedman TC. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013; 36: 260-266.
37. Dutta D, Mondal SA, Choudhuri S, Maisnam I, Hasanoor Reza AH, Bhattacharya B et al. Vitamin-D supplementation in prediabetes reduced progression to type 2 diabetes and was associated with decreased insulin resistance and systemic inflammation: An open label randomized prospective study from Eastern India. Diabetes Res Clin Pract 2014; 103: e18-e23.
38. Oosterwerff MM, Eekhoff EM, Van Schoor NM, Boeke AJ, Nanayakkara P, Meijnen R et al. Effect of moderate-dose vitamin D supplementation on insulin sensitivity in vitamin D-deficient non-Western immigrants in the Netherlands: a randomized placebo-controlled trial. Am J Clin Nutr 2014; 100: 152-160.
39. Sollid ST, Hutchinson MY, Fuskevag OM, Figenschau Y, Joakimsen RM, Schirmer H et al. No effect of high-dose vitamin D supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetes. Diabetes Care 2014; 37: 2123-2131.
40. Nazarian S, St Peter JV, Boston RC, Jones SA, Mariash CN. Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose. Transl Res 2011; 158: 276-281.
41. Naharci I, Bozoglu E, Kocak N, Doganci S, Doruk H, Serdar M. Effect of vitamin D on insulin sensitivity in elderly patients with impaired fasting glucose. Geriatr Gerontol Int 2012; 12: 454-460.
42. Parildar H, Cigerli O, Unal DA, Gulmez O, Demirag NG. The impact of vitamin D replacement on glucose metabolism. Pak J Med Sci 2013; 29: 1311-1314.
43. Tai K, Need AG, Horowitz M, Chapman IM. Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. Nutrition 2008; 24: 950-956.
44. Ljunghall S, Lind L, Lithell H, Skarfors E, Selinus I, Sorensen OH et al. Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance-a prospective randomized double-blind study. Acta Med Scand 1987; 222: 361-367.
45. Lind L, Lithell H, Skarfors E, Wide L, Ljunghall S. Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance. Acta Med Scand 1988; 223: 211-217.
46. Hoseini SA, Aminorroaya A, Iraj B, Amini M. The effects of oral vitamin D on insulin resistance in pre-diabetic patients. J Res Med Sci 2013; 18: 47-51.
47. Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009; 26: 19-27.
48. Abbasi F, Brown BW Jr, Lamendola C, McLaughlin T, Reaven GM. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 2002; 40: 937-943.
49. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481-486.
50. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.
51. Didriksen A, Grimnes G, Hutchinson MS, Kjaergaard M, Svartberg J, Joakimsen RM et al. The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to genetic factors, BMI, and baseline levels. Eur J Endocrinol 2013; 169: 559-567.
52. Saliba W, Barnett-Griness O, Rennert G. The relationship between obesity and the increase in serum 25(OH)D levels in response to vitamin D supplementation. Osteoporos Int 2013; 24: 1447-1454.
53. Jorde R, Sneve M, Emaus N, Figenschau Y, Grimnes G. Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromso study. Eur J Nutr 2010; 49: 401-407.
54. Blum M, Dallal GE, Dawson-Hughes B. Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults. J Am Coll Nutr 2008; 27: 274-279.
55. Kayaniyil S, Retnakaran R, Harris SB, Vieth R, Knight JA, Gerstein HC et al. Prospective associations of vitamin D with beta-cell function and glycemia: the prospective metabolism and islet cell evaluation (PROMISE) cohort study. Diabetes 2011; 60: 2947-2953.
56. Su Z, Narla SN, Zhu Y. 25-Hydroxyvitamin D: analysis and clinical application. Clin Chim Acta 2014; 433: 200-205.
57. Carter GD. 25-hydroxyvitamin D: a difficult analyte. Clin Chem 2012; 58: 486-488.
58. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006; 29: 650-656.
59. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 2013; 36: 3821-3842.
60. Haffner S, Temprosa M, Crandall J, Fowler S, Goldberg R, Horton E et al. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 2005; 54: 1566-1572.
61. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H et al. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care 1999; 22: 399-402.
62. Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 2007; 78: 305-312.